TrialVirology journal2016

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients.

Song Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.